Matches in SemOpenAlex for { <https://semopenalex.org/work/W2050319978> ?p ?o ?g. }
Showing items 1 to 69 of
69
with 100 items per page.
- W2050319978 endingPage "612" @default.
- W2050319978 startingPage "611" @default.
- W2050319978 abstract "Reply: We are happy to respond to Dr. Zhou's considerations on our study comparing 15% hypertonic sodium pyruvate (HPY) with 8% hypertonic NaCl (HS) in the treatment of sheep with multiple hemorrhages (1). Dr Zhou's main contention is that the conclusion of our study should be the opposite, that is, HPY offers benefits over HS in the initial phase of hemorrhagic shock resuscitation, although he states that according to the conditions of our study, on the surface, no initial advantage of HPY was seen. Based on our data, we rejected our first hypothesis: a small volume of HPY is superior to osmotically and volume-matched HS for improving acute metabolic dysfunction, base deficit, and lactate/pyruvate (L/P) ratio imbalance. In addition, we rejected our second hypothesis: HPY improves hemodynamics and reduces fluid volume for similar hemodynamics. These are the only reasonable conclusions that can be reached based on the data. We do appreciate that any animal study is limited by certain model considerations. Conclusions must be considered with respect to the model used. Our study only addressed the acute effects of fluid resuscitation in a moderate hemorrhagic hypovolemia, a common clinical presentation requiring fluid therapy. We used a closed-loop resuscitation system with a physiological target end point of 90 mmHg to infuse the first 4 mL/kg of HPY or HS, followed by lactate Ringer, in both groups. In the discussion, we state, It may be that our conscious model of shock was not severe enough to see a benefit of pyruvate. Dr. Zhou misquotes us, the shock model was not severe enough to show benefit of pyruvate. Dr. Zhou also wrote, if the MAP further dropped and remained at 40 mmHg as shown in the Mongan et al. hemorrhagic model (2), the prospective cardiovascular benefits of pyruvate: less hemodynamic decompensation, a higher cardiac output level, and lowered lactate/pyruvate (L/P) ratio would be predictable to appear in this experiment. This is conjecture. In our study, after the first hemorrhage of 25 mL/kg, MAP decreased to 40 mmHg, and there was no observed cardiovascular benefit of HPY resuscitation. In addition, oxygen delivery was lower with HPY than that with HS resuscitation. No hemodynamic and systemic oxygenation advantages were apparent with HPY. It is a reach to extrapolate from our data that HPY offered benefits over HS for resuscitation based on the transient variations in pH, lactate, and HCO3−. Our study shows that shock increased lactate similarly in both groups, and with the HS, it slowly recovered but increased 3-fold with the pyruvate. This is a consequence of how pyruvate is metabolized, and we do not think that this is a particular advantage or disadvantage. There was rapid alkalinization using HPY in our model. However, we do not consider this to be of benefit in shock because an increased hydrogen ion concentration is an important stimulus for several compensatory mechanisms for both cardiovascular and pulmonary function. The L/P ratio is an indicator of the metabolic status (2, 3) and was not suggestive of benefit for HPY because L/P was significantly higher than HS 120 min after the beginning of treatment. Dr. Zhou said that HPY not only avoids hyperchloremia-induced renal dysfunction but also protects kidney function in ischemia and oxidative stress and pointed this as an advantage in our study. We did not evaluate renal function in our model. However, based on similar models in which renal function has been studied, resuscitation with either hypertonic saline or lactated Ringer in euhydrated and dehydrated sheep, no renal dysfunction was found due to hyperchloremia (4). Finally, references to support Dr. Zhou's several contentions would have been helpful, for example: Evidently, in order to prevent HPY from alkalosis, it is essential to reduce the dosage or concentration of HPY from 15% to 11.0% (1.0 M, or less) of NaPyr in shock resuscitation. Substitution of 1/2 NaCl in 7.2% HS with equimolar NaPyr: 3.5% NaCl/7.0% NaPyr (the ratio may vary) would be superior to current HS solutions. In ischemia or hypoxia, the new pyruvate-containing HS in resuscitation would not only prevent iatrogenic hyperchloremic acidosis in addition to the improvement of disturbed glucose metabolic pathways, but also correct original metabolic (lactic) acidosis induced by severe shock, and provide the protection of vital organ function as well. We wait to read the peer-reviewed results of the experimental or clinical use of such solutions. Paulo do Nascimento, Jr George C. Kramer Resuscitation Research Laboratory Department of Anesthesiology, UTMB Galveston, Texas" @default.
- W2050319978 created "2016-06-24" @default.
- W2050319978 creator A5046897477 @default.
- W2050319978 creator A5054232363 @default.
- W2050319978 date "2008-11-01" @default.
- W2050319978 modified "2023-10-18" @default.
- W2050319978 title "Pyruvate is superior to chloride in hypertonic saline in resuscitation." @default.
- W2050319978 cites W1820824149 @default.
- W2050319978 cites W1972267629 @default.
- W2050319978 cites W2057866859 @default.
- W2050319978 doi "https://doi.org/10.1097/shk.0b013e31817fc3c5" @default.
- W2050319978 hasPublicationYear "2008" @default.
- W2050319978 type Work @default.
- W2050319978 sameAs 2050319978 @default.
- W2050319978 citedByCount "0" @default.
- W2050319978 crossrefType "journal-article" @default.
- W2050319978 hasAuthorship W2050319978A5046897477 @default.
- W2050319978 hasAuthorship W2050319978A5054232363 @default.
- W2050319978 hasBestOaLocation W20503199781 @default.
- W2050319978 hasConcept C117277713 @default.
- W2050319978 hasConcept C126322002 @default.
- W2050319978 hasConcept C178853913 @default.
- W2050319978 hasConcept C185592680 @default.
- W2050319978 hasConcept C2777324261 @default.
- W2050319978 hasConcept C2777397205 @default.
- W2050319978 hasConcept C2778165595 @default.
- W2050319978 hasConcept C2781300812 @default.
- W2050319978 hasConcept C2781309813 @default.
- W2050319978 hasConcept C2993366118 @default.
- W2050319978 hasConcept C3017567848 @default.
- W2050319978 hasConcept C42219234 @default.
- W2050319978 hasConcept C55493867 @default.
- W2050319978 hasConcept C71924100 @default.
- W2050319978 hasConceptScore W2050319978C117277713 @default.
- W2050319978 hasConceptScore W2050319978C126322002 @default.
- W2050319978 hasConceptScore W2050319978C178853913 @default.
- W2050319978 hasConceptScore W2050319978C185592680 @default.
- W2050319978 hasConceptScore W2050319978C2777324261 @default.
- W2050319978 hasConceptScore W2050319978C2777397205 @default.
- W2050319978 hasConceptScore W2050319978C2778165595 @default.
- W2050319978 hasConceptScore W2050319978C2781300812 @default.
- W2050319978 hasConceptScore W2050319978C2781309813 @default.
- W2050319978 hasConceptScore W2050319978C2993366118 @default.
- W2050319978 hasConceptScore W2050319978C3017567848 @default.
- W2050319978 hasConceptScore W2050319978C42219234 @default.
- W2050319978 hasConceptScore W2050319978C55493867 @default.
- W2050319978 hasConceptScore W2050319978C71924100 @default.
- W2050319978 hasIssue "5" @default.
- W2050319978 hasLocation W20503199781 @default.
- W2050319978 hasLocation W20503199782 @default.
- W2050319978 hasOpenAccess W2050319978 @default.
- W2050319978 hasPrimaryLocation W20503199781 @default.
- W2050319978 hasRelatedWork W1975926347 @default.
- W2050319978 hasRelatedWork W2050319978 @default.
- W2050319978 hasRelatedWork W2129351692 @default.
- W2050319978 hasRelatedWork W2270133592 @default.
- W2050319978 hasRelatedWork W2356036990 @default.
- W2050319978 hasRelatedWork W2370551338 @default.
- W2050319978 hasRelatedWork W2389368918 @default.
- W2050319978 hasRelatedWork W2390617604 @default.
- W2050319978 hasRelatedWork W2428611062 @default.
- W2050319978 hasRelatedWork W4255391483 @default.
- W2050319978 hasVolume "30" @default.
- W2050319978 isParatext "false" @default.
- W2050319978 isRetracted "false" @default.
- W2050319978 magId "2050319978" @default.
- W2050319978 workType "article" @default.